
Shares of drugmaker Merck MRK.N fall 2% to $113.11 premarket
Co says 2026 revenue will be $65.5 bln–$67 bln, with the high end below analysts’ $67.6 bln forecast and profit also came in below Wall Street estimates
Co reports Q4 adj.profit of $2.04/shr vs analysts' average estimate of $2.01/shr - LSEG data
Co's quarterly revenue of $16.4 billion beats analysts' average expectation of $16.19 billion
Shares up ~6% in 2025